Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Aalborg Universitet |
| Country | Denmark |
| Start Date | May 01, 2021 |
| End Date | Apr 30, 2026 |
| Duration | 1,825 days |
| Number of Grantees | 20 |
| Roles | Participant; Coordinator |
| Data Source | European Commission |
| Grant ID | 899871 |
Multimorbidity is a common condition in older age, and can substantially influence individuals’ health and quality of life, making management more difficult.
A single-disease approach with fragmented care is still prevalent in current healthcare systems despite multimorbidity representing a heterogeneous spectrum of disease combination(s).
On this background, the novel approach underpinning the AFFIRMO project is to focus on clusters of multimorbidity where atrial fibrillation(AF) represents one of the chronic conditions.
Improving the management of AF in the context of multimorbidity may benefit individuals on a larger scale, with a holistic approach to optimize clinical management of older AF patients taking into account the multifaceted aspects of individuals’ health, including multimorbidity, polypharmacy, personal preferences, and social context.
First, the project aims to identify different clusters of multimorbidity in older patients with AF.
Second, AFFIRMO aims to assess the needs of patients, caregivers, and health professionals for the comprehensive management of multimorbidity including AF, and to examine ways of optimizing care and self-management.
Third, AFFIRMO will develop, implement and test the effectiveness of a patient-centered approach on older multimorbid AF patients in the clinical practice. We aim to adapt, implement and promote a care pathway, in older patients with multimorbidity.
A specific objective will be to develop an interoperable care framework that can facilitate the application of this personalized care pathway, that bridges the continuum between primary and secondary care, with the active involvement of patients with shared decision-making.
A further aim will be to model the impact of multimorbidity including AF on healthcare costs and the health economic benefits by the proposed integrated care pathway. Finally, subgroup analyses would assess differences on outcomes of in relation to gender and social inequalities.
Meditcinsky Universitet-Plovdiv; The University of Manchester; Universiteit Gent; Advice Pharma Group Srl; Istituto Superiore Di Sanita; Faculty of Medicine, Universityersity of Belgrade; Universita Degli Studi Di Padova; Moverim Srl; Universidad de Murcia; Consiglio Nazionale Delle Ricerche; European Union Geriatric Medicine Society Aisbl; The University of Liverpool; Karolinska Institutet; Arrhythmia Alliance; Ontonix Srl; Aalborg Universitet; Universitatea de Medicina Si Farmacie Carol Davila Din Bucuresti; Universita Cattolica Del Sacro Cuore; The European Institute for Innovation Through Health Data; Fondazione Per Il Tuo Cuore Onlus
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant